-

Mexedia S.p.A. Società Benefit – Completion of the Sale of Telvantis Voice Services

ROME--(BUSINESS WIRE)--Regulatory News : 

Mexedia S.p.A. (Euronext Growth Paris: ALMEX) announces that the transaction relating to the sale of Telvantis Voice Services, a company previously controlled by its subsidiary Telvantis, has been completed with effect as of 31 December 2025

Share

Mexedia S.p.A. Società Benefit (Euronext Growth Paris: ALMEX, ISIN IT0005450819) announces that the transaction relating to the sale of Telvantis Voice Services, Inc. (“TVS”), a company previously controlled by its subsidiary Telvantis, has been completed with effect as of 31 December 2025, as publicly disclosed by Spectral Capital Corporation in its press release dated 5 January 2026.

According to the information released by Spectral Capital Corporation, the transaction was completed pursuant to the definitive stock purchase agreement announced on 29 December 2025 and resulted in Spectral Capital acquiring 100% of the issued and outstanding equity of Telvantis Voice Services, Inc.

As previously communicated by Mexedia, the transaction is structured as a stock-for-stock exchange and includes earn-out mechanisms linked to the achievement of defined revenue and operating profit targets for the 2026 financial year, as disclosed by Spectral Capital Corporation.

Further details on the transaction are available in the official press release published by Spectral Capital Corporation, accessible at the following link:

Spectral Capital Closes Telvantis Acquisition as Important Milestone Toward 2026 $450 Million Profitable Revenue Goal

Mexedia confirms that, following the closing of the transaction, Telvantis Voice Services is no longer part of the perimeter of the Mexedia Group. Further details relating to the acquisition and its financial implications are available in Spectral Capital Corporation’s public disclosures and regulatory filings.

About Mexedia

Mexedia S.p.A. Società Benefit is a company listed on Euronext Growth Paris, active in technology services and communication solutions. The Group operates internationally, working with clients and partners across multiple markets and developing industrial models aimed at medium- to long-term growth and value creation.

Information pursuant to the Market Abuse Regulation (MAR)

This press release is issued pursuant to Article 17 of Regulation (EU) No. 596/2014 (Market Abuse Regulation).

The information relating to the transaction involving Telvantis Voice Services is based on publicly available disclosures made by Spectral Capital Corporation.

This press release contains forward-looking statements. Such statements are based on current expectations and assumptions of the Company and involve risks and uncertainties that could cause actual results to differ materially.

Contacts

Mexedia S.p.A. Società Benefit
Investor Relations
Vincenzo La Barbera
investor.relations@mexedia.com

Mexedia S.p.A. Società Benefit

BOURSE:ALMEX
Details
Headquarters: Rome, Italy
CEO: Paolo Bona
Employees: 10
Organization: PUB

Release Versions

Contacts

Mexedia S.p.A. Società Benefit
Investor Relations
Vincenzo La Barbera
investor.relations@mexedia.com

More News From Mexedia S.p.A. Società Benefit

Mexedia S.p.A. Società Benefit: Management Discipline and Operational Approach in the Group’s Evolution Path

ROME--(BUSINESS WIRE)--Regulatory News: Mexedia S.p.A. Società Benefit (Euronext Growth Paris: ALMEX, ISIN: IT0005450819), as part of the evolution path initiated in 2024 and continued in 2025, confirms its commitment to strengthening management discipline and adopting an operational approach focused on efficiency, quality of activities and long-term sustainability. During the last financial year, the Group implemented a set of actions aimed at streamlining its operating perimeter and progressi...

Mexedia S.p.A. Società Benefit: Approval of the Draft Statutory and Consolidated Financial Statements as of December 31, 2025

ROME--(BUSINESS WIRE)--Regulatory News: The Board of Directors of Mexedia S.p.A. Società Benefit (Euronext Growth Paris: ALMEX, ISIN: IT0005450819), meeting today, approved the draft statutory financial statements and the consolidated financial statements for the year ended December 31, 2025. ✓ Consolidated revenues at €118.1 million (+62.0% compared to €72.9 million in 2024) ✓ Gross margin at €10.2 million (+38.2% compared to €7.4 million in 2024) ✓ EBITDA at €-1.2 million (improving from €-23...

Mexedia Among the Leading Teams at Race for the Cure 2026

ROME--(BUSINESS WIRE)--Regulatory News: Mexedia S.p.A. Società Benefit (Euronext Growth Paris: ALMEX, ISIN: IT0005450819) is pleased to announce that, as part of its participation in the Race for the Cure 2026, the Mexedia & Friends team currently ranks fifth among the teams with the highest number of registered participants. This result continues to grow day by day and represents much more than a numerical milestone: an increasing number of people are choosing to join Mexedia & Friends...
Back to Newsroom